Charges Mount Against Guidant As J&J Deal Sours

Law360, New York (November 7, 2005, 12:00 AM EST) -- Embattled medical device maker Guidant Corporation can now add a federal investigation to its growing list of financial and legal worries, as the Securities and Exchange Commission has initiated a formal probe into the company’s product disclosures.

Guidant did not reveal any of the details of the investigation, but issued a statement saying that the company intended to fully comply with the SEC.

The investigation comes as Guidant’s financial and legal troubles continue to mount.

The company said Monday that it intended to sue healthcare giant...
To view the full article, register now.